Background
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) was originally isolated from human plasma albumin in the 1970s and found to promote tissue repair and anti-inflammatory signaling. Subsequent research revealed it as a naturally occurring human tripeptide that declines with age — from ~200 ng/mL at age 20 to ~80 ng/mL by age 60.
Pickart and Margolina’s 2018 review leveraged modern transcriptomic databases — particularly analyses of the NIH LINCS program — to systematically characterize how GHK-Cu modulates human gene expression across multiple organ systems.
Key Findings
Gene Expression Profile:
- GHK-Cu significantly altered expression of ~4,000 human genes in transcriptomic analyses
- Upregulated: genes involved in collagen synthesis, extracellular matrix assembly, antioxidant enzymes (SOD2, catalase), wound healing growth factors
- Downregulated: pro-inflammatory cytokines (IL-6, TNF-α), matrix metalloproteinases (collagen-degrading enzymes), cancer metastasis genes
Tissue Systems Affected:
| System | Effect |
|---|---|
| Skin/dermis | Collagen I/III upregulation, fibroblast activation |
| Nervous system | BDNF/NGF upregulation, nerve growth promotion |
| Immune system | Anti-inflammatory cytokine modulation |
| Liver | Protective gene expression pattern |
| Lung | Antifibrotic signaling |
Anti-Aging Mechanisms:
- GHK-Cu reset gene expression patterns in fibroblasts aged in culture toward a younger phenotype
- Activated Nrf2 antioxidant pathway genes — the same pathway targeted by sulforaphane and rapamycin
- Suppressed TGF-β1 signaling that drives fibrosis and aging-related tissue stiffening
Clinical Significance
GHK-Cu’s transcriptomic profile explains its documented multi-tissue effects:
- Skin regeneration: Collagen/elastin promotion is the basis for its topical cosmetic applications
- Wound healing: Growth factor upregulation consistent with accelerated wound closure in animal models
- Systemic anti-aging: The breadth of beneficial gene modulation — spanning antioxidant, anti-inflammatory, and regenerative pathways — positions GHK-Cu as a potential systemic anti-aging peptide
The decline of endogenous GHK-Cu with age mirrors the deterioration of these same biological processes, suggesting GHK-Cu repletion could restore youthful tissue maintenance signaling.
Limitations
- Gene expression data is correlative; causal mechanisms require functional validation
- Most findings are from cell culture or animal tissue; human systemic pharmacology is not established
- Transcriptomic breadth makes target identification and pathway prioritization difficult
- Bioavailability after SC administration is not well characterized